REVIEW article
Front. Pharmacol.
Sec. Neuropharmacology
Review of Clinical Advances in the Procedural Sedation Application of Remimazolam
Provisionally accepted
Shuancheng Bai*
奇伟 王- 内蒙古医科大学, 呼和浩特市, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
With the continuous advancement of comfort-oriented healthcare, procedural sedation has been widely adopted in clinical practice. As a newer benzodiazepine introduced in recent years, remimazolam has demonstrated unique advantages in the field of procedural sedation. This article explores the pharmacologic properties of remimazolam and its clinical applications in procedural sedation, aiming to provide comprehensive guidance for rational clinical use and advance the drug's development in relevant fields.
Keywords: Anesthesia4, benzodiazepines2, ProceduralSedation5, remimazolam1, Sedative3
Received: 06 Nov 2025; Accepted: 11 Feb 2026.
Copyright: © 2026 Bai and 王. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shuancheng Bai
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.